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Over time, chronically elevated systemic inflammation contributes to many chronic diseases, 
including cardiovascular disease, cancer, and type 2 diabetes.  Dietary fat intake has long been 
assumed to contribute to chronic systemic inflammation, but the effects of dietary macronutrient 
composition on inflammatory biomarkers have not been clearly established.  While dietary fat might 
increase inflammation through increased fat mass, inflammatory effects independent from changes 
in body weight have also been suggested.  In order to better measure these associations, Drs. 
Xiaoling Song, Mario Kratz, and colleagues in the Public Health Sciences Division evaluated 
changes in inflammatory biomarkers among participants on different diets in a randomized controlled 
feeding study.  As recently reported in the European Journal of Nutrition, the researchers found that 
adiponectin concentrations were substantially lowered in individuals consuming a low-fat high-
carbohydrate diet compared to those consuming a moderate-fat diet. 
Systemic inflammation can be measured through circulating biomarkers such as C-reactive protein 
(CRP), interleukin-6 (IL-6), and the soluble tumor necrosis factor receptors I and II (sTNFRI and 
sTNFRII).  In addition to these four biomarkers of systemic inflammation, adiponectin levels can also 
be used as a marker of adipose tissue inflammation.  An adipocyte-derived hormone with anti-
inflammatory and insulin-sensitizing effects, adiponectin is inversely associated with 
adiposity.  Increased body fat is associated with low-grade chronic adipose tissue inflammation.  As 
this inflammation suppresses the secretion of adiponectin from adipocytes, decreased adiponectin 
levels can be considered a marker of increased adipose tissue inflammation.  
To evaluate the effects of dietary macronutrient composition on inflammation biomarker 
concentrations, the researchers conducted a secondary analysis of samples available from the Fatty 
Acids Marker Evaluation (FAME) study.  This randomized controlled feeding trial consisted of 92 
individuals assigned to one of three diets.  Two of these were eucaloric diets, consisting of sufficient 
calories to maintain body weight, while a third diet provided 33% fewer calories.  These diets differed 
in macronutrient content (see figure), consisting of either moderate-fat (36% fat, 46% carbohydrate) 
or low-fat high-carbohydrate (18% fat, 64% carbohydrate) intake.  Plasma biomarker concentrations 
were measured at baseline, and then again after 6 weeks of the assigned diet. 
April 20, 2015 SCIENCE SPOTLIGHT 
 
2 Volume 5, Issue 4 | Fred Hutchinson Cancer Research Center 
 
 
After 6 weeks on these diets, the researchers found no differences in these biomarkers for systemic 
inflammation.  For adipose tissue inflammation, the authors did find that adiponectin concentrations 
tended to be increased in those who lost weight, as expected.  After adjusting for weight change, 
however, the authors found that adiponectin levels were significantly reduced, by about 10%, in 
those eating low-fat diets compared to the moderate-fat diet (p=0.008).  "This may be of concern 
because plasma adiponectin concentrations are inversely associated with the risk of type 2 diabetes, 
coronary heart disease, hypertension, and a variety of cancers," said lead author Dr. Xiaoling Song. 
This surprising finding should motivate future research of long-term macronutrient intake on 
inflammatory biomarkers.  Said Dr. Song, "it is not clear whether the reduction in fat intake per se, 
the increase in carbohydrates, or a shift in the fat-to-carbohydrate ratio was the cause of the 
decreased adiponectin concentrations.  This again demonstrates the difficulty in studying the effects 
of specific dietary components. However, although there were differences in carbohydrate quality 
between diets (i.e. the amount of fiber and added sugars were higher in the low-fat diet than those in 
the moderate-fat diet), our diets mimicked the carbohydrate choices that free-living individuals are 
likely to make when consuming moderate vs. low fat diets in the real world. Therefore, our results 
are relevant to real world situations, and do raise a new concern for the health effects of consuming 
very-low fat diets." 
Other researchers from the Public Health Sciences Division contributing to this project were Ms. 
Yvonne Schwarz, Pamela Yang, and Xiaojun Hu, as well as Drs. Mark Kestin and Johanna Lampe. 
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Image provided by Dr. Xiaoling Song 
Macronutrient content (percent of total energy intake) in FAME 
Study diets. 
 
